Tvardi Therapeutics Inc
NASDAQ:TVRD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tvardi Therapeutics Inc
NASDAQ:TVRD
|
US |
Intrinsic Value
The intrinsic value of Tvardi Therapeutics Inc (TVRD) under the Base Case is 7.1779 USD per share.
Compared with the current market price of 0.9722 USD, the stock appears
Undervalued by 86% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Tvardi Therapeutics Does
Cara Therapeutics is a biopharmaceutical company that develops prescription medicines for severe itch and pain. Its work has centered on drug candidates that act on the body’s opioid receptors, especially the kappa opioid receptor, which it studies as a way to relieve symptoms without relying on traditional painkillers. In simple terms, it is a drug developer, not a drug distributor or clinic operator.
- Headquarters
- United States of America US
- Employees
- 12
- IPO date
- Jan 31, 2014
Revenue & Expenses Breakdown
Tvardi Therapeutics Inc
Earnings Waterfall
Tvardi Therapeutics Inc
The intrinsic value for Tvardi Therapeutics Inc (TVRD) under the Base Case is 7.1779 USD.
Compared with the current market price of 0.9722 USD, the stock appears Undervalued by 86% .